BridgeBio has substantially boosted its progress of a novel therapy for amyloid heart disease, utilizing the compound. Early clinical data reveals promising benefits for those suffering from the severe illness. The https://bridgebio922033.xzblogs.com/82481200/company-advances-amyloidosis-treatment-using-the-therapy